Scarab Genomics said it has entered into an exclusive licensing partnership with Bionova Scientific, granting Bionova rights to use one of Scarab’s proprietary Clean Genome® E. coli strains for plasmid DNA production. The agreement supports pDNA manufacturing for advanced biologics
Eurofins CDMO Alphora said its Canadian-based division is receiving advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program to support a research and development collaboration focused on next-generation antibody-drug conjugate production. The project aims
OXB said it has expanded its strategic partnership with Bristol Myers Squibb through a new Commercial Supply Agreement covering the manufacture and supply of lentiviral vectors for CAR-T programs. The agreement builds on an existing relationship between the companies that
Charles River Laboratories said it will close its cell therapy contract development and manufacturing site in Hanover, Maryland, resulting in the elimination of 20 positions. The closure was disclosed in a state Worker Adjustment and Retraining Notification filing. The decision
Thermo Fisher Scientific said it will close a manufacturing facility in Franklin, Massachusetts, and eliminate up to 80 positions as part of an ongoing effort to adjust its manufacturing footprint. The decision was disclosed in an updated state Worker Adjustment
Naresta, one of Lithuania’s largest construction companies, has completed a new logistics centre for the Stem Cell Research Center, a company within the Northway group and the Northway Biotech cluster. The project was delivered in nine months and represents the
BioDlink has announced the successful go-live of Veeva QMS, marking a milestone in the company’s quality digitalization strategy. The system entered operation following a launch event on January 29 attended by representatives from Veeva and the joint project team. The
Samsung Biologics has announced a partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to strengthen global vaccine manufacturing preparedness for future epidemic and pandemic threats. As part of the agreement, Samsung Biologics will join CEPI’s Vaccine Manufacturing Facility Network,
AGC Biologics has announced that its Seattle manufacturing facility has received Good Manufacturing Practices certification from Brazil’s health regulator, Agência Nacional de Vigilância Sanitária (Anvisa). The approval allows biologics and biosimilars manufactured at the site to be commercialized in Brazil,
Cellares has announced a collaboration with the Stanford Center for Definitive and Curative Medicine and the Stanford Innovative Medicines Accelerator to automate manufacturing and release testing for gene-edited hematopoietic stem cell therapies. The effort expands the use of Cellares’ automation
